PHILADELPHIA -- Following initial therapy, salvage therapy with a peptide receptor radionuclide agent, 177 Lu-DOTA,Tyr 3-octreotate, was beneficial for those with bronchial or gastroenteropancreatic ...
Prophylactic Urokinase in the Management of Long-Term Venous Access Devices in Children: A Children's Oncology Group Study Fifty patients who had been treated with 600 to 800 mCi of 177 Lu-octreotate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback